Quantitative MRI for Patients With Sickle Cell Disease Undergoing Hematopoietic Cell Transplant
- Conditions
- Sickle Cell Disease
- Interventions
- Diagnostic Test: serial functional magnetic resonance imaging (MRI)
- Registration Number
- NCT03458897
- Lead Sponsor
- University of Michigan
- Brief Summary
The primary purpose of this research is to determine if it is feasible to perform serial magnetic resonance imaging (MRI) to evaluate the amount of bone marrow cells (also called cellularity) and iron stores before and after bone marrow transplantation for severe sickle cell disease.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 7
- Age ≥ 5 years.
- Diagnosis of SCD ([Hemoglobin SS (Hb-SS), Hemoglobin SC (Hb-SC) or Hemoglobin S-Beta thalassemia (Hb-Sβ) genotype].
- Patient is a candidate for an allogeneic HCT.
- Subject or guardians have given informed consent.
Exclusion Criteria
- The need for general anesthesia for MRI.
- Subjects with implanted magnetic devices (e.g. pacemakers) that may malfunction or move in the strong magnetic field.
- A subject who is pregnant.
- Previous HCT.
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description MRI arm serial functional magnetic resonance imaging (MRI) Subjects with sickle cell disease undergoing bone marrow transplantation will undergo serial functional MRI (up to 4 scans).
- Primary Outcome Measures
Name Time Method Feasibility of obtaining serial scans in patients with sickle cell undergoing marrow transplant 110 days post transplant Feasibility will be measured by the number of subjects who undergo at least 2 of 4 scheduled functional MRI's
- Secondary Outcome Measures
Name Time Method MRI and neutrophil engraftment 1 year post transplant Correlation between functional MRI result and time to neutrophil engraftment
MRI and hemoglobin S. 1 year post transplant Correlation between functional MRI result and hemoglobin S level.
MRI and chimerism 1 year post transplant Correlation between functional MRI result and time to donor/ recipient chimerism
Trial Locations
- Locations (1)
University of Michigan
🇺🇸Ann Arbor, Michigan, United States